OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sotrovimab: First Approval
Young‐A Heo
Drugs (2022) Vol. 82, Iss. 4, pp. 477-484
Open Access | Times Cited: 53
Young‐A Heo
Drugs (2022) Vol. 82, Iss. 4, pp. 477-484
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Development of therapeutic antibodies for the treatment of diseases
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 75
Zeng Wang, Guoqing Wang, Huaqing Lu, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 75
Efficacy and safety of sotrovimab in patients with COVID‐19: A rapid review and meta‐analysis
Bahman Amani, Behnam Amani
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 29
Bahman Amani, Behnam Amani
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 29
Monoclonal antibodies – A repertoire of therapeutics
Suman Tapryal
Advances in protein chemistry and structural biology (2025), pp. 151-212
Closed Access
Suman Tapryal
Advances in protein chemistry and structural biology (2025), pp. 151-212
Closed Access
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 255-255
Open Access
Jiayang Wang, Qi Qian, Yushan Jiang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 255-255
Open Access
Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis
Norah Htet Htet, Han You Kyung, Ismail Abdul Sattar Burud, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
Norah Htet Htet, Han You Kyung, Ismail Abdul Sattar Burud, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
Antivirals for Broader Coverage against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system
Yu‐Sheng Yu, Haiyue Xu, Khaled AboulFotouh, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123892-123892
Closed Access | Times Cited: 4
Yu‐Sheng Yu, Haiyue Xu, Khaled AboulFotouh, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123892-123892
Closed Access | Times Cited: 4
Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
Oana Săndulescu, Cătălin Apostolescu, Liliana Preoțescu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Oana Săndulescu, Cătălin Apostolescu, Liliana Preoțescu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis
Guangyu Ao, Toni Li, Yushu Wang, et al.
Journal of Infection (2022) Vol. 85, Iss. 1, pp. e10-e12
Open Access | Times Cited: 11
Guangyu Ao, Toni Li, Yushu Wang, et al.
Journal of Infection (2022) Vol. 85, Iss. 1, pp. e10-e12
Open Access | Times Cited: 11
Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
Aram Yegiazaryan, Arbi Abnousian, Logan J. Alexander, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9297-9297
Open Access | Times Cited: 11
Aram Yegiazaryan, Arbi Abnousian, Logan J. Alexander, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9297-9297
Open Access | Times Cited: 11
An Overview of Repurposed Drugs for Potential COVID-19 Treatment
Kamini Govender, Anil A. Chuturgoon
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1678-1678
Open Access | Times Cited: 11
Kamini Govender, Anil A. Chuturgoon
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1678-1678
Open Access | Times Cited: 11
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Use of Sotrovimab in a cohort of pregnant women with a high risk of COVID 19 progression: a single-center experience
Luisa Frallonardo, Antonella Vimercati, Roberta Novara, et al.
Pathogens and Global Health (2023) Vol. 117, Iss. 5, pp. 513-519
Closed Access | Times Cited: 5
Luisa Frallonardo, Antonella Vimercati, Roberta Novara, et al.
Pathogens and Global Health (2023) Vol. 117, Iss. 5, pp. 513-519
Closed Access | Times Cited: 5
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Mary Wu, Scott T.C. Shepherd, Annika Fendler, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 821-823
Open Access | Times Cited: 5
Mary Wu, Scott T.C. Shepherd, Annika Fendler, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 821-823
Open Access | Times Cited: 5
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Bill Thaddeus Padasas, Erica Españo, Sang‐Hyun Kim, et al.
Immune Network (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 5
Bill Thaddeus Padasas, Erica Españo, Sang‐Hyun Kim, et al.
Immune Network (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 5
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis
Behnam Amani, Bahman Amani
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 547-555
Closed Access | Times Cited: 1
Behnam Amani, Bahman Amani
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 547-555
Closed Access | Times Cited: 1
Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19
Zeyuan Zheng, Huimin Sun, Xiao Hu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Zeyuan Zheng, Huimin Sun, Xiao Hu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
A computational method for anti-SARS-CoV-2 antibodies neutralization power: A blueprint with monoclonal antibody Sotrovimab (Preprint)
Dana Ashoor, Maryam Marzouq, M. Dahmani Fathallah
JMIR Bioinformatics and Biotechnology (2024) Vol. 5, pp. e58018-e58018
Open Access | Times Cited: 1
Dana Ashoor, Maryam Marzouq, M. Dahmani Fathallah
JMIR Bioinformatics and Biotechnology (2024) Vol. 5, pp. e58018-e58018
Open Access | Times Cited: 1
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry
Diego F. Wyszynski, Lydia Demetriou, Cheryl Renz, et al.
Drug Safety (2024) Vol. 47, Iss. 9, pp. 843-851
Open Access | Times Cited: 1
Diego F. Wyszynski, Lydia Demetriou, Cheryl Renz, et al.
Drug Safety (2024) Vol. 47, Iss. 9, pp. 843-851
Open Access | Times Cited: 1
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2
Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104126-104126
Closed Access | Times Cited: 1
Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104126-104126
Closed Access | Times Cited: 1
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo
Vaccines (2024) Vol. 12, Iss. 11, pp. 1220-1220
Open Access | Times Cited: 1
Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants
Sandipan Chakraborty, Aditi Saha, Chiranjeet Saha, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 627, pp. 168-175
Open Access | Times Cited: 8
Sandipan Chakraborty, Aditi Saha, Chiranjeet Saha, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 627, pp. 168-175
Open Access | Times Cited: 8
Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis
Negin Farhadian, Maryam Farhadian, Mohammad Hossein Zamanian, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 45, Iss. 4, pp. 402-408
Closed Access | Times Cited: 8
Negin Farhadian, Maryam Farhadian, Mohammad Hossein Zamanian, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 45, Iss. 4, pp. 402-408
Closed Access | Times Cited: 8
Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica
Jennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5551-5551
Open Access | Times Cited: 4
Jennifer Jessica Eisler, Giulio Disanto, Rosaria Sacco, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5551-5551
Open Access | Times Cited: 4
